NO20061515L - Anvendelse av okskarbazepin for behandling av diabetisk neurpatisk smerte og forbedring av sovn - Google Patents
Anvendelse av okskarbazepin for behandling av diabetisk neurpatisk smerte og forbedring av sovnInfo
- Publication number
- NO20061515L NO20061515L NO20061515A NO20061515A NO20061515L NO 20061515 L NO20061515 L NO 20061515L NO 20061515 A NO20061515 A NO 20061515A NO 20061515 A NO20061515 A NO 20061515A NO 20061515 L NO20061515 L NO 20061515L
- Authority
- NO
- Norway
- Prior art keywords
- pain
- sleep
- improvement
- treatment
- oxcarbazepine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Den foreliggende oppfinnelsen tilveiebringer nye anvendelser av karbamazepinderivatet med formel (I) og dets farmasøytiske akseptable salter, i særdeleshet et forbedret regime for administrering av karbamazepinderivatet med formel (I) og de farmasøytiske akseptable saltene derav for behandling av pasienter som lider av smerte, i særdeleshet neuropatisk smerte, spesielt diabetisk neuropatisk smerte, og forbedring av søvn, anvendelse av okskarbazepin for fremstilling av en farmasøytisk sammensetning for behandling av smerte eller fremstilling av en farmasøytisk sammensetning for forbedring av søvn hos humane pasienter som lider av kronisk smerte, farmasøytiske sammensetninger som innbefatter okskarbazepin som eneste aktive ingrediens for behandling av smerte eller for forbedring av søvn hos humane pasienter som lider av kronisk smerte og pakninger som omfatter en farmasøytisk sammensetning som innbefatter som eneste aktive ingrediens, okskarbazepin, sammen med instruksjoner for behandling av smerte eller sammen med instruksjoner for forbedring av søvn hos humane pasienter som lider av kronisk smerte.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0320637A GB0320637D0 (en) | 2003-09-03 | 2003-09-03 | Organic compounds |
| US53737804P | 2004-01-16 | 2004-01-16 | |
| PCT/EP2004/009797 WO2005020968A2 (en) | 2003-09-03 | 2004-09-02 | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20061515L true NO20061515L (no) | 2006-06-06 |
Family
ID=34276821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20061515A NO20061515L (no) | 2003-09-03 | 2006-04-03 | Anvendelse av okskarbazepin for behandling av diabetisk neurpatisk smerte og forbedring av sovn |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20060270658A1 (no) |
| EP (1) | EP1663247B1 (no) |
| JP (1) | JP2007513056A (no) |
| KR (1) | KR20060118426A (no) |
| AT (1) | ATE446759T1 (no) |
| AU (1) | AU2004268381B2 (no) |
| BR (1) | BRPI0414112A (no) |
| CA (1) | CA2537060A1 (no) |
| DE (1) | DE602004023861D1 (no) |
| IL (1) | IL173822A0 (no) |
| IS (1) | IS8373A (no) |
| MA (1) | MA28036A1 (no) |
| MX (1) | MXPA06002392A (no) |
| NO (1) | NO20061515L (no) |
| RU (1) | RU2369393C2 (no) |
| SG (1) | SG146631A1 (no) |
| TN (1) | TNSN06072A1 (no) |
| WO (1) | WO2005020968A2 (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
| GB0603008D0 (en) * | 2006-02-14 | 2006-03-29 | Portela & Ca Sa | Method |
| MX2008013675A (es) * | 2006-04-26 | 2009-03-06 | Supernus Pharmaceuticals Inc | Preparaciones de liberacion controlada de oxcarbacepina que tienen perfil de liberacion sigmoidal. |
| GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
| KR102486435B1 (ko) | 2022-04-25 | 2023-01-10 | 주식회사 제이비플랜트 | 산업용 냉동기기의 친환경 패널의 제조 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH500196A (de) | 1969-03-10 | 1970-12-15 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Azepinderivaten |
| US4353887A (en) | 1979-08-16 | 1982-10-12 | Ciba-Geigy Corporation | Divisible tablet having controlled and delayed release of the active substance |
| CO4920215A1 (es) | 1997-02-14 | 2000-05-29 | Novartis Ag | Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones |
| GB9925962D0 (en) * | 1999-11-02 | 1999-12-29 | Novartis Ag | Organic compounds |
| GB9930058D0 (en) | 1999-12-20 | 2000-02-09 | Novartis Ag | Organic compounds |
| GB0128674D0 (en) * | 2001-11-30 | 2002-01-23 | Boots Co Plc | Treatment of sleep disorders and the like |
| CA2497780A1 (en) * | 2002-10-17 | 2004-04-29 | Novartis Ag | Pharmaceutical composition for treating pain comprising oxicarbazepine, or derivatives thereof, and cox2 inhibitors |
-
2004
- 2004-09-02 RU RU2006110550/15A patent/RU2369393C2/ru not_active IP Right Cessation
- 2004-09-02 EP EP04764755A patent/EP1663247B1/en active Active
- 2004-09-02 KR KR1020067004340A patent/KR20060118426A/ko not_active Application Discontinuation
- 2004-09-02 CA CA002537060A patent/CA2537060A1/en not_active Abandoned
- 2004-09-02 AU AU2004268381A patent/AU2004268381B2/en not_active Ceased
- 2004-09-02 AT AT04764755T patent/ATE446759T1/de not_active IP Right Cessation
- 2004-09-02 US US10/570,340 patent/US20060270658A1/en not_active Abandoned
- 2004-09-02 DE DE602004023861T patent/DE602004023861D1/de active Active
- 2004-09-02 WO PCT/EP2004/009797 patent/WO2005020968A2/en active Application Filing
- 2004-09-02 SG SG200806736-5A patent/SG146631A1/en unknown
- 2004-09-02 BR BRPI0414112-1A patent/BRPI0414112A/pt not_active IP Right Cessation
- 2004-09-02 JP JP2006525105A patent/JP2007513056A/ja active Pending
- 2004-09-02 MX MXPA06002392A patent/MXPA06002392A/es not_active Application Discontinuation
-
2006
- 2006-02-20 IL IL173822A patent/IL173822A0/en unknown
- 2006-03-02 TN TNP2006000072A patent/TNSN06072A1/en unknown
- 2006-03-10 MA MA28869A patent/MA28036A1/fr unknown
- 2006-03-24 IS IS8373A patent/IS8373A/is unknown
- 2006-04-03 NO NO20061515A patent/NO20061515L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0414112A (pt) | 2006-10-31 |
| IS8373A (is) | 2006-03-24 |
| EP1663247A2 (en) | 2006-06-07 |
| WO2005020968A3 (en) | 2005-05-19 |
| JP2007513056A (ja) | 2007-05-24 |
| IL173822A0 (en) | 2006-07-05 |
| TNSN06072A1 (en) | 2007-10-03 |
| MXPA06002392A (es) | 2006-06-20 |
| RU2369393C2 (ru) | 2009-10-10 |
| KR20060118426A (ko) | 2006-11-23 |
| AU2004268381B2 (en) | 2009-06-18 |
| CA2537060A1 (en) | 2005-03-10 |
| SG146631A1 (en) | 2008-10-30 |
| EP1663247B1 (en) | 2009-10-28 |
| MA28036A1 (fr) | 2006-07-03 |
| WO2005020968A2 (en) | 2005-03-10 |
| DE602004023861D1 (de) | 2009-12-10 |
| US20060270658A1 (en) | 2006-11-30 |
| ATE446759T1 (de) | 2009-11-15 |
| AU2004268381A1 (en) | 2005-03-10 |
| RU2006110550A (ru) | 2007-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200800056A1 (ru) | Каннабиноидный активный фармацевтический ингредиент для лекарственных форм | |
| WO2008027557A3 (en) | Topiramate compositions and methods of enhancing its bioavailability | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| DE60121301D1 (de) | Flibanserin zur Behandlung extrapyramidaler Bewegungsstörungen | |
| EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
| MX2009011900A (es) | Curacion de herida diabetica. | |
| TW200603787A (en) | Topical preparations containing ambroxol | |
| BRPI0111591B8 (pt) | composto, composição farmacêutica, e, usos de um composto | |
| EA200702204A1 (ru) | Лечение заболеваний соединительной ткани кожи | |
| DOP2005000039A (es) | Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
| MX2012000275A (es) | Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal. | |
| DE50203456D1 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
| MA32639B1 (fr) | [4-(5-aminométhyl-2-fluoro-phényl)-pipéridin- 1-yl]-[7-fluoro-1- (2-méthoxy-éthyl)-4-trifluorométhoxy-1h-indol-3-yl]-méthanone en tant qu'inhibiteur de la tryptase de mastocytes | |
| CY1115973T1 (el) | Συνδυασμος ινσουλινης με παραγωγα τριαζινης και χρηση αυτου για θεραπεια διαβητη | |
| EA200600817A1 (ru) | Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты) | |
| NO20061515L (no) | Anvendelse av okskarbazepin for behandling av diabetisk neurpatisk smerte og forbedring av sovn | |
| GB2446341A (en) | Method and system for transdermal drug delivery | |
| NO20053032L (no) | Anvendelse av 2,5-dihydroxybenzensulfoniske forbindelser for behandling av lidelser basert pa en forstyrrelse av NO produksjon og/eller av regulering av EDHF funksjon. | |
| DK1675611T3 (da) | Terapeutiske anvendelser for C-peptid | |
| TW200626133A (en) | Oral medication for twice-daily administration | |
| TW200515912A (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep | |
| DE60327249D1 (de) | Anthranilsäureamide und ihre pharmazeutische verwendung | |
| DK1265629T3 (da) | Anvendelse af væksthormon i lav dosis | |
| EA200501366A1 (ru) | Лекарственное средство |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |